Zhengye Biotechnology Holding (ZYBT) Current Deferred Revenue (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Current Deferred Revenue of $669996.8 for Q4 2025, up 23.88% year-over-year from $540853.1 in Q4 2024, and down 4.01% quarter-over-quarter from $698000.0 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Current Deferred Revenue (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Current Deferred Revenue for 3 consecutive years, with $669996.8 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Deferred Revenue rose 23.88% year-over-year to $669996.8; the TTM figure through Dec 2025 stood at $669996.8 (up 23.88% YoY), while the FY2025 annual figure was $680000.0, up 42.56% from the prior year.
- Current Deferred Revenue retreated to $669996.8 in Q4 2025 per ZYBT's latest filing, from $698000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $698000.0 in Q2 2025 and bottomed at $540853.1 in Q4 2024.
- Historically, Current Deferred Revenue has averaged $636967.7 across 3 years, with a median of $654508.9 in 2023.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue fell 15.36% — and 2025, when it rose 23.88%.
- Zhengye Biotechnology Holding's Current Deferred Revenue stood at $639020.9 in 2023, then retreated by 15.36% to $540853.1 in 2024, then increased by 23.88% to $669996.8 in 2025.
- Business Quant data shows ZYBT's Current Deferred Revenue at $669996.8 in Q4 2025, $698000.0 in Q2 2025, and $540853.1 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Zhengye Biotechnology Holding | 88.07 Mn | 80.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 669,996.84 |
| Jun 30, 2025 | 698,000.00 |
| Dec 31, 2024 | 540,853.07 |
| Dec 31, 2023 | 639,020.90 |